4//SEC Filing
Bornstein Yoseph 4
Accession 0001493152-18-000089
CIK 0000883975other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:12 PM ET
Size
5.5 KB
Accession
0001493152-18-000089
Insider Transaction Report
Form 4
Bornstein Yoseph
Director10% Owner
Transactions
- Sale
Common Stock
2018-01-02$1.01/sh−42,132$42,515→ 4,568,277 total(indirect: By LSA- LifeScience Accelerator Ltd.)
Footnotes (2)
- [F1]Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 42,132 shares of Issuer common stock on January 2, 2018. Accordingly, Reporting Person beneficially owned 4,568,277 shares of Issuer common stock following the reported transactions.
- [F2]Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.
Documents
Issuer
Microbot Medical Inc.
CIK 0000883975
Entity typeother
Related Parties
1- filerCIK 0001690100
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 3:12 PM ET
- Size
- 5.5 KB